NTLA·45826J105·US·equity·Healthcare - Biotechnology-13D/G
NTLA (INTELLIA THERAPEUTICS INC) is held by 149 institutional investors as of Q1 2026. Largest holders: ARK Investment Management LLC ($186M), BlackRock, Inc. ($155.8M), STATE STREET CORP ($88.7M). Net institutional sentiment: Mixed.
See how NTLA's score breaks down across 4 SEC sources
Showing 1-20 of 167
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer